Filtered By:
Condition: Heart Failure
Management: Hospitals
This page shows you your search results in order of relevance. This is page number 19.
Order by Relevance | Date
Total 519 results found since Jan 2013.
Efficacy and Efficiency of Perioperative Stellate Ganglion Blocks in Cardiac Surgery: A Pilot Study
Nationally, postoperative atrial fibrillation (POAF) occurs in up to 40% of patients after coronary artery bypass grafting (CABG), 50% of patients after valve surgery, 64% of patients after mitral valve and CABG, and 49% after aortic valve replacement.1 Atrial fibrillation worsens a patient ’s hemodynamic status and increases the risk of congestive heart failure, embolic events, and longer intensive care unit stays, leading to increased patient morbidity and strain on financial resources. In the United States, POAF carries a higher risk of stroke, worsened survival, and an additional 4.9 days and $10,000 to $11,500 in hospital stay costs.
Source: Journal of Cardiothoracic and Vascular Anesthesia - November 20, 2017 Category: Anesthesiology Authors: Christopher W. Connors, Wendy Y. Craig, Scott A. Buchanan, Justin M. Poltak, James B. Gagnon, Craig S. Curry Tags: Letter to the Editor Source Type: research
Patient characteristics, resource use and outcomes associated with general internal medicine hospital care: the General Medicine Inpatient Initiative (GEMINI) retrospective cohort study.
We examined trends in resource use and patient characteristics over the study period.
RESULTS: There were 136 208 admissions to general internal medicine involving 88 121 unique patients over the study period. General internal medicine admissions accounted for 38.8% of all admissions from the emergency department and 23.7% of all hospital bed-days. Over the study period, the number of admissions to general internal medicine increased by 32.4%; there was no meaningful change in the median length of stay or cost per hospital stay. The median patient age was 73 (interquartile range [IQR] 57-84) years, and the median ...
Source: cmaj - December 11, 2017 Category: General Medicine Authors: Verma AA, Guo Y, Kwan JL, Lapointe-Shaw L, Rawal S, Tang T, Weinerman A, Cram P, Dhalla IA, Hwang SW, Laupacis A, Mamdani MM, Shadowitz S, Upshur R, Reid RJ, Razak F Tags: CMAJ Open Source Type: research
The impact of non-alcoholic fatty liver disease fibrosis score on cardiac prognosis in patients with chronic heart failure
AbstractLiver abnormalities have a strong impact on clinical outcomes in patients with heart failure (HF), and are known as cardio-hepatic syndrome. The non-alcoholic fatty liver disease (NAFLD) fibrosis score (NFS) has been developed to identify liver fibrosis in patients with NAFLD. It remains to be determined whether NFS is associated with cardiovascular prognosis in patients with chronic heart failure (CHF). We calculated NFS in 516 patients with CHF admitted to our hospital. The clinical endpoints were deaths due to progressive HF, myocardial infarction, stroke, and sudden cardiac death, and rehospitalization for wors...
Source: Heart and Vessels - December 29, 2017 Category: Cardiology Source Type: research
How Loud Noise Exposure Is Linked to Heart Disease
If you live near an airport, railroad tracks or a busy road, you might be concerned about how fumes from those planes, trains and automobiles are affecting your health. But according to a new review in the Journal of the American College of Cardiology, there may be another threat to worry about: high levels of noise that may be bad for your heart.
A connection between noise pollution and cardiovascular disease has been observed in numerous studies over the years, the authors of the new review said. High decibel levels from road traffic and airplanes, for example, has been linked to high blood pressure, coronary artery dise...
Source: TIME: Health - February 6, 2018 Category: Consumer Health News Authors: Amanda MacMillan Tags: Uncategorized are loud noises unhealthy healthytime Heart Disease heart disease risks heart health Journal of the American College of Cardiology noise level meter noise meter noise pollution noise-cancelling headphones onetime Rese Source Type: news
EBR Systems launches trial for wireless pacer
EBR Systems said yesterday that it launched a 350-patient investigational device exemption trial of its Wise wireless pacemaker it hopes to use to win FDA approval.
Sunnyvale, Calif.-based EBR’s device uses a subcutaneous generator to wirelessly deliver ultrasound energy to a “pellet” implanted in the right ventricle, which it uses to synchronize the left and right ventricles. The system is designed to eliminate the need for a left ventricular lead by allowing the operating physician to place the stimulation “pellet” in a patient-specific location inside the left ventricle.
The FDA approved the Solve-CRT stu...
Source: Mass Device - March 8, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Clinical Trials Cardiac Rhythm Management EBR Systems Inc. Source Type: news
New cardiac pump device improves long-term outcomes for heart failure patients
(Brigham and Women's Hospital) New findings, presented today at the American College of Cardiology, provide long-term information about survival, stroke rates and durability of a novel centrifugal-flow pump compared with a commercial axial flow pump for heart-failure patients.
Source: EurekAlert! - Medicine and Health - March 11, 2018 Category: International Medicine & Public Health Source Type: news
Medtronic touts reduced AF, improved activity in AdaptivCRT studies
Medtronic (NYSE:MDT) today released results from two real-world analyses of its AdaptivCRT algorithm, touting that its use was linked to a reduction in atrial fibrillation episodes and higher patient activity levels.
Results from the analyses, which involved a total of 408 patients at 26 centers in Italy, were presented at the European Heart Rhythm Association’s Scientific Sessions 2018 in Barcelona, Spain, the company said.
Medtronic’s AdaptivCRT algorithm is designed to adjust pacing to the heart dependent upon evaluations of heart rhythm made every minute, the company said. The program has been shown to in...
Source: Mass Device - March 20, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Assist Devices Cardiac Implants Cardiovascular Clinical Trials Software / IT Medtronic Source Type: news
O5.7. risk of diabetic complications and subsequent mortality among individuals with schizophrenia and diabetes mellitus: a nationwide population-based register study
DiscussionUnexpectedly, we found individuals with comorbid schizophrenia and diabetes mellitus to have a similar or lower rate of diabetic complications diagnosed in hospitals compared to individuals with diabetes mellitus only. However, we still found an excess mortality following a diagnosis of a diabetic complication among individuals with schizophrenia. These results may indicate that individuals are not even seen in hospitals with their diabetic complications and hence indicate an increased need for improved somatic care of individuals with schizophrenia if the burden of diabetes mellitus morbidity and mortality should be reduced.
Source: Schizophrenia Bulletin - April 1, 2018 Category: Psychiatry Source Type: research
Contemporary Reviews in Critical Care Medicine: Atrial Fibrillation in the Intensive Care Unit.
We describe acute- and long-term evaluation and management strategies based on current evidence, and propose future avenues of investigation to fill large knowledge gaps in the management of patients with AF during critical illness.
PMID: 29627355 [PubMed - as supplied by publisher]
Source: Chest - April 5, 2018 Category: Respiratory Medicine Authors: Bosch NA, Cimini J, Walkey AJ Tags: Chest Source Type: research
Chronic Right Heart Failure
Right heart failure is caused by right heart dysfunction resulting in suboptimal stroke volume to supply the pulmonary circulation. Therapeutic developments mean that patients with acute right heart failure survive to hospital discharge and live with chronic right heart failure. Chronic right heart failure management aims to reduce afterload, optimize preload, and support contractility, with the best evidence available in vascular targeted therapy for pulmonary arterial hypertension. However, the management of chronic right heart failure relies on adapting therapies for left ventricular heart failure to the right. We revie...
Source: Heart Failure Clinics - July 1, 2018 Category: Cardiology Authors: Mwelwa Chizinga, Wassim H. Fares Source Type: research
Medtronic ’s HVAD System Just Became Less Invasive
Medtronic has gained FDA approval for a less-invasive implant approach of its HVAD System, a left ventricular assist device (LVAD) for advanced heart failure patients. The Dublin-based company picked up the technology when it acquired HeartWare in 2016. The firm said the technology is the only LVAD approved in the U.S. for implant via thoracotomy, a small lateral, surgical incision between the patient's ribs on the left side of the chest.
FDA approval for HVAD implantation via thoracotomy is based on data from the LATERAL prospective clinical trial, in which 144 patients, with end-stage heart failure who were eligible for ...
Source: MDDI - July 12, 2018 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Business Source Type: news
Protease inhibitors may increase risk of death in people with HIV and heart failure
Ritonavir-boosted protease inhibitors associated with doubled risk of hospital readmission and cardiovascular death Related items fromOnMedica Stroke rate higher in HIV patients £30 million to tackle antimicrobial resistance Single-dose malaria drug eliminates parasite from liver Ibuprofen not a safe alternative to antibiotics for uncomplicated UTIs Too few women take part in many CVD clinical trials
Source: OnMedica Latest News - July 24, 2018 Category: UK Health Source Type: news
Acute coronary syndromes and heart failure CCU utilization and outcomes in teaching and community hospitals: A national population based analysis
Publication date: Available online 29 July 2018Source: Canadian Journal of CardiologyAuthor(s): Sanam Verma, Padma Kaul, Meng Lin, Justin A. Ezekowitz, David A. Zygun, Christopher B. Fordyce, Tracy Y. Wang, Finlay A. McAlister, Sean van DiepenAbstractAcute coronary syndromes (ACS) and heart failure (HF) are the leading diagnoses in patients admitted to critical care units (CCU). Little is known about the differences between CCU resource utilization and outcomes across hospital types. The Canadian Institute for Health Information was used to identify patients hospitalized with a primary diagnosis of an ACS or HF. CCUs were ...
Source: Canadian Journal of Cardiology - July 29, 2018 Category: Cardiology Source Type: research
The Hemodynamic Profile of GI Bleeding in Continuous-Flow LVADs: Is it All About the Right Ventricle?
The last decade has seen LVADs emerge as an effective and durable means to support select patients with advanced heart failure. Despite improvements in heart failure morbidity and mortality with mechanical support, device-related complications remain a challenge. While rates of pump thrombosis, driveline infection and stroke have declined with improvements in pump design and patient care strategies, the risk of gastrointestinal (GI) bleeding has remained constant.1 GI bleeding remains the leading cause of hospital readmission following device implant, occurring in 30% of patients with continuous-flow LVADs and negatively i...
Source: Journal of Cardiac Failure - August 2, 2018 Category: Cardiology Authors: Christopher T. Sparrow, Joel D. Schilling Source Type: research
Sex-Specific Trends in Incidence and Mortality for Urban and Rural Ambulatory Heart Failure Patients in Eastern Ontario from 1994-2013
Heart failure (HF) remains a significant cause of morbidity and mortality with an estimated lifetime risk of 1 in 5.1,2 Despite the current era of goal directed medical therapy, HF continues to be a leading cause of admission to hospital, it is associated with a poor prognosis and contributes to 35% of total female cardiovascular mortality.3 Urban-rural differences in morbidity, mortality, access to care, medication utilization and cost of care have been reported in many cohorts of cardiovascular disease, including stroke,4 acute myocardial infarction,5 stable ischemic heart disease6 and acute heart failure;7,8 only one of...
Source: Journal of Cardiac Failure - August 9, 2018 Category: Cardiology Authors: Louise Y. Sun, Jack V. Tu, Heather Sherrard, Norvinda Rodger, Thais Coutinho, Michele Turek, Elizabeth Chan, Heather Tulloch, Lisa McDonnell, Lisa M. Mielniczuk Source Type: research
